Johnson & Johnson (NYSE:JNJ)

What to Expect When Johnson & Johnson Reports Tuesday

Posted: October 14, 2019 at 12:10 pm

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.00 in earnings per ...
Read Full Story »

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Posted: October 13, 2019 at 6:50 am

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. The Dow is hovering near its all-time high, just as this ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Posted: October 11, 2019 at 8:50 am

Stocks were indicated to open sharply higher on Brexit hopes and U.S./China trade hopes, and earnings season will kick off next week. The bull market is now well over 10 ...
Read Full Story »

Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling

Posted: October 9, 2019 at 12:25 pm

The announcement that a jury has awarded $8 billion in damages to a man accusing Johnson & Johnson (NYSE: JNJ) of failing to warn about the side effects of ...
Read Full Story »

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

Posted: October 2, 2019 at 10:50 am

Johnson & Johnson (NYSE: JNJ) surprised investors on Wednesday morning by announcing a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial. While this in and ...
Read Full Story »

Unusual Settlement Deal Proposed for Opioid Lawsuits

Posted: October 1, 2019 at 12:00 pm

Five pharmaceuticals makers are proposing an unusual method for settling hundreds of the more than 2,500 lawsuits facing drugmakers that made and sold opioid painkillers. The five companies want to ...
Read Full Story »

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Posted: September 30, 2019 at 7:30 am

With just over one quarter left in 2019, it has been another banner year for stock market investors, with double-digit gains in all three major averages. Barring a big end-of-the-year ...
Read Full Story »

As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus

Posted: September 13, 2019 at 7:11 am

With all the talk of trade war, recessions, inverted yield curves and negative interest rates in August and the start of September, many investors have every right to feel duped. ...
Read Full Story »

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

Posted: August 27, 2019 at 11:25 am

When companies run into legal issues in which they face potentially endless numbers of trials in numerous venues in America, it can create a tough time managing them. Johnson & ...
Read Full Story »

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Posted: August 12, 2019 at 12:10 pm

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Posted: July 18, 2019 at 7:20 am

Johnson & Johnson (NYSE: JNJ) saw its shares get hit after earnings, but it was more than just the earnings and guidance to blame. Along with issues around ongoing talcum ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

Posted: July 17, 2019 at 9:10 am

Stocks were looking for direction as earnings season gets started. The bull market is now well over 10 years old, and 2019 has seen very strong stock market gains, with ...
Read Full Story »